Bococizumab is a cutting-edge anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. Such therapeutic agent interacts with the PCSK9 protein, a critical regulator of cholesterol amounts. By https://deannamvyo070494.blog-gold.com/57283884/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia